Genta To Support Initiation Of New Clinical Trial Using Ganite(R) As Treatment For Life-Threatening Infections In Patients With Cystic Fibrosis
Originally posted in Cystic Fibrosis News From Medical News Today
Genta Incorporated (OTCBB: GETA) announced that the Company will supply Ganite® (gallium nitrate injection) for a new clinical trial that will be initiated in patients with cystic fibrosis (CF) who may develop serious infections. Infection is the most common cause of death in CF patients…
No Comments
RSS feed for comments on this post.
by Raelene
